The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on April 27, 2026

Apr. 27, 2026

PEO4YOU Integrates Medical Debt Relief Contributions Into Benefits Consulting Business Model

Indeterminate EIN Presswire

Apr. 27, 2026

ApsTron Science Introduces Patent-Pending PhysioWatch™ for Continuous Physiological Monitoring

Indeterminate EIN Presswire

Apr. 27, 2026

Adaptive Sports New England Receives $30,000 Grant From The Hartford

Indeterminate EIN Presswire

Apr. 27, 2026

VARStreet Now Supports SCIM-Based User Provisioning with Microsoft Entra ID

Indeterminate EIN Presswire

Apr. 27, 2026

Respiratory Care Professor, MedTech Co-Founder Presents Novel Neonate Breathing Technology at PAS Meeting in Boston

Indeterminate EIN Presswire

Apr. 27, 2026

ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Tessera Therapeutics to Present New Preclinical Data Supporting In Vivo Program in Sickle Cell Disease and Advancements in In Vivo CAR-T Applications at the American Society of Gene and Cell Therapy 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

SES LAWSUIT: SES AI Corp. Sued for Securities Fraud; Investors Should Contact Block & Leviton to Possibly Recover Losses

Indeterminate GlobeNewswire

Apr. 27, 2026

Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCE™ Platform at 2026 ASGCT Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease

Indeterminate GlobeNewswire

Apr. 27, 2026

Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences

Indeterminate GlobeNewswire

Apr. 27, 2026

Rgenta Therapeutics Announces Two Oral Presentations Highlighting Proprietary RSwitch Technology at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Beta Bionics to Present at the Bank of America Securities Health Care Conference

Indeterminate GlobeNewswire

Apr. 27, 2026

Northeast Bank Reports Third Quarter Results and Declares Dividend

Indeterminate GlobeNewswire

Apr. 27, 2026

Intellia Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire

Apr. 27, 2026

POET Technologies Inc. Investors Should Contact Block & Leviton to Find Out How They Might Recover Losses Through The Firm’s Investigation

Indeterminate GlobeNewswire

Apr. 27, 2026

AI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive Innovation

Indeterminate GlobeNewswire

Apr. 27, 2026

Choosing a Global High-Purity Fluorinated Building Blocks Vendor for Modern Labs: AiFChem

Indeterminate EIN Presswire